TipRanks
Go Ultimate55% OFF
PC:VIVER

Vivere Oncotherapies: Valuation, Funding & Investors

2625 Durant Ave Berkeley, California 94704, UShttps://viveretx.com/Therapeutics

Vivere Oncotherapies is a UC Berkeley spin-out developing cancer therapies that activate the immune system to detect and destroy cancer cells in immunologically cold tumors. The company leverages a proprietary bioengineering platform to design targeted immunotherapies that reach tumors more efficiently and provide treatments for difficult-to-treat solid tumors such as colorectal and ovarian cancers.

Leadership & Board

Current Number of Employees
11
Current LinkedIn Followers
1,106

Latest Estimated Valuation

Total Amount Raised
$10M
Total Funding Rounds
1
Latest Funding Amount
$10M
Latest Funding Round
Investment

Employee Trend

Vivere Oncotherapies had 11 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.

11Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026

Social Trend

Vivere Oncotherapies had 1,106 followers as of October 26, 2026. The number of followers increased by 7 (0.64%) week-over-week.

1,106Latest Followers Count
7(0.64%)Week-Over-Week Change
05001,0001,5002,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 13, 2026Investment$10.00M―

Investors

Investor NameFunding Round
Freeflow VenturesInvestment
YK BioventuresInvestment
Berkeley Frontier FundInvestment
PillarInvestment
National Cancer InstituteInvestment

Similar Companies

A snapshot of private companies similar to Vivere Oncotherapies, helping you discover and navigate related company profiles.

Related News and Analysis